Araim Pharmaceuticals
Tarrytown · Founded 2006
About Araim Pharmaceuticals
Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases. Its lead compound, ARA 290, a novel 11 amino acid peptide, stimulates tissue protective, reparative, and anti-inflammatory signaling pathways through selective IRR activation. Araim Pharmaceuticals is based in Tarrytown, New York.
Company Facts
- Founded: 2006
- Legal name: Araim Pharmaceuticals, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Last round: Series Unknown (Nov 2014)
- Website: araimpharma.com
- Phone: +1-914-762-7586
Social Profiles
Canonical: https://fsome.com/organization/araim-pharmaceuticals-8454474 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.